首页> 外国专利> METHOD OF TREATMENT OF LIVER PRIMARY CANCER AND SET FOR TREATMENT OF LIVER PRIMARY CANCER

METHOD OF TREATMENT OF LIVER PRIMARY CANCER AND SET FOR TREATMENT OF LIVER PRIMARY CANCER

机译:肝癌的治疗方法及肝癌的治疗装置

摘要

FIELD: medicine, oncology. SUBSTANCE: method involves administration of doxorubicin dissolved in lipiodol ultrafluid in hepatic artery. Doxorubicin preparation is doxorubicin-estrone dissolved in 96% ethyl alcohol at 70-76 C at dose 20-60 mg in 10-15 ml lipiodol ultrafluid. Preliminary (before 20 min) alpha-fetoprotein is administrated in hepatic artery at dose 2-10 mg in 12-15 ml physiological solution, and repeated treatment is carried out in 3-4 weeks. The set contains sterile doxorubicin-estrone at amount 20-60 mg in vials (volume is 15 ml), sterile lipiodol ultrafluid in two ampoules (volume of each is 10 ml) and additionally - sterile lyophilized human alpha-fetoprotein at amount 1-10 mg in vials (volume is 10 ml), sterile physiological solution (15 ml in ampoule) and 96% ethyl alcohol (5 ml in ampoule). EFFECT: improved method of cancer treatment. 2 cl
机译:领域:医学,肿瘤学。物质:该方法涉及给予溶解在肝动脉中碘油超流体中的阿霉素。阿霉素制剂是将阿霉素雌酮在70-76°C下以20-60 mg的剂量溶于10-15 ml碘油超流体中溶于96%乙醇中。在肝动脉中以2-10 mg的剂量在12-15 ml生理溶液中初步(20分钟之前)施用甲胎蛋白,并在3-4周内重复治疗。这套药在小瓶中含有20-60 mg的无菌阿霉素-雌酮(体积为15 ml),在两个安瓿中含有无菌的碘油超流体(每个体积为10 ml),此外-无菌冻干的人甲胎蛋白含量为1-10装在小瓶中(每瓶10毫升),无菌生理溶液(在安瓿瓶中为15毫升)和96%的乙醇(在安瓿瓶中为5毫升)。效果:改进的癌症治疗方法。 2厘升

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号